Access to information contained on this website is exclusively reserved for professional investors in Luxembourg. Please read the important information below. This contains legal and regulatory information which applies to our company status, use of this website and information about any investment in our products referred to in this website. Note that you will have to accept these terms and conditions before you can proceed. Copyright 2021 by Nordea Investment Funds S.A. – all rights reserved.
Please note that you are required to read and accept the terms of our privacy policy and the use of cookies before you are able to access our websites.
For full privacy and cookie policy please refer to the link below.
Access to information contained on this website is exclusively reserved for investors in Luxembourg. Please read the important information below. This contains legal and regulatory information which applies to our company status, use of this website and information about any investment in our products referred to in this website. Note that you will have to accept these terms and conditions before you can proceed. Copyright 2021 by Nordea Investment Funds S.A. – all rights reserved.
Please note that you are required to read and accept the terms of our privacy policy and the use of cookies before you are able to access our websites.
For full privacy and cookie policy please refer to the link below.
You have requested to view an article or page that is not available in your domain, selected language and/or to your investor type.
Go to Home PageApril 2020
Nordea Dedicated Investment Fund, SICAV-FIS
Société d’Investissement à Capital Variable
562, rue de Neudorf, L-2220 Luxembourg
R.C.S. Luxembourg B 150516
INFORMATION UPDATE
IMPORTANT INFORMATION: In view of the COVID-19 outbreak, Nordea Dedicated Investment Fund, SICAV-FIS is taking precautionary measures to limit the exposure for its shareholders and other stakeholders. Given the outbreak of the COVID-19 and the related limitations on travel and large gatherings, this year’s annual general meeting will be held without a physical presence, as permitted by Luxembourg law. In view thereof, arrangements have been made to provide shareholders with the opportunity to vote by proxy voting in electronic form (please refer to the practicalities herein). |
The shareholders of Nordea Dedicated Investment Fund, SICAV-FIS (the “Company”) are hereby informed that due to the exceptional COVID-19 situation and in compliance with article 1.(1) of the Grand Ducal regulation of 20th March 2020 introducing measures concerning meetings in companies and other legal entities, no physical attendance of the annual general meeting of shareholders to be held on 23 April 2020 at 12:00 CET (the “Meeting”) will be possible.
Shareholders are herewith provided with the possibility to express their vote by means of proxy voting submitted in electronic form. Proxies issued in their former form and already received before 14 April 2020 remain valid.
In order to vote at the Meeting, shareholders are invited to send the duly completed and signed proxy form attached hereto to arrive no later than 20 April 2020, 17:00 CET by e-mail to [email protected].
Luxembourg, 14 April 2020
IMPORTANT
Shareholders are invited to send a duly completed and signed proxy form to arrive no later than 20 April 2020, 17:00 CET by e-mail to [email protected] |
POWER OF ATTORNEY
I, the undersigned
«Name»
«Address1»
«Address2»
«Address3»
«Account ID XXXXXXXX»
owner of ______________ shares of Nordea Dedicated Investment Fund, SICAV-FIS (the “Company”), having its registered office in 562, rue de Neudorf, L-2220 Luxembourg hereby appoint the
Jeremie Houet, Head of Corporate Law of Nordea Investment Funds S.A. (Chairperson)
as my proxy holder to represent me and vote in my name and on my behalf at the annual general meeting of shareholders of the Company on 23 April 2020 at 12:00 CET (the “Meeting”), with the following resolutions to be adopted:
For | Against | Abstention | ||
1 | Submission of the reports of the board of directors of the Company (the “Board of Directors” and each member individually a “Director”) and of the Company’s approved statutory auditor for the fiscal year ended 31 December 2019 (the “Auditor”); | |||
2 | Approval of the balance sheet and the profit and loss statement for the fiscal year ended 31 December 2019; | |||
3 | Allocation of net results; | |||
4 | Discharge to the Directors and the Auditor in respect of the carrying out of their duties during the financial year ended 31 December 2019; | |||
5 | Appointment of Directors and the approved statutory Auditor of the Company; |
The proxy holder shall have the broadest powers whatsoever, including the power of substitution, to represent and bind the undersigned at the said Meeting or any subsequent meeting having the same agenda, to take part in all deliberations and to vote in my name and on my behalf any resolution, to sign any document and generally to do anything necessary or useful in relation with the contemplated agenda.
Date________________________Signature(s)__________________________________________
Nordea Dedicated Investment Fund, SICAV-FIS
562, rue de Neudorf
P.O. Box 782
L-2017 Luxembourg
Tel + 352 27 86 51 00
Fax + 352 27 86 50 11
[email protected]
nordea.lu
Registre de Commerce Luxembourg No B 150516, Registered office: 562, rue de Neudorf, L-2220 Luxembourg